Enanta Pharmaceuticals
ENTA
#7336
Rank
NZ$0.78 B
Marketcap
NZ$27.03
Share price
-2.62%
Change (1 day)
139.86%
Change (1 year)

EPS for Enanta Pharmaceuticals (ENTA)

EPS in 2025 (TTM): NZ-$6.63

According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$6.56. In 2024 the company made an earnings per share (EPS) of NZ-$8.48.

EPS history for Enanta Pharmaceuticals from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.63-21.83%
2024NZ-$8.48
2021NZ-$8.5372.92%
2020NZ-$4.93-267.44%
2019NZ$2.95-61.35%
2018NZ$7.62147.22%
2017NZ$3.08-460%
2016NZ-$0.86-114.88%
2015NZ$5.75-23.81%
2014NZ$7.55-244.12%
2013NZ-$5.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AbbVie
ABBV
NZ$2.32-135.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$17.88-372.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$24.54-474.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.01-298.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.09-177.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.61-292.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland